Sickle Cell | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Infection | | Disease | Target | ATF-2 Protein | | | | | | |
Anxiety | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Cholesterol | | Disease | Target | Glutathione Peroxidase 6 | | | | | | |
Aralen (Chloroquine)- FDA | | Drug | Drug | Acitretin (Soriatane)- FDA | | | | | | |
Thromboembolic Disease | | Disease | Drug | Angiomax (Bivalirudin)- FDA | | | | | | |
Diabetes | | Disease | Disease | Nephropathy Diabetic | | | | | | |
Obesity | | Disease | Drug | Alpha (Prolastin)- FDA | | | | | | |
Acute Coronary Syndromes | | Disease | Drug | Angiomax (Bivalirudin)- FDA | | | | | | |
Renin | | Target | Target | ATF-2 Protein | | | | | | |
Deep Vein Thrombosis | | Disease | Drug | Angiomax (Bivalirudin)- FDA | | | | | | |
Analgesia | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Alefacept (Amevive)- FDA | | Drug | Drug | Acitretin (Soriatane)- FDA | | | | | | |
Panic Disorder | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Hearing Loss | | Disease | Target | Glutathione Peroxidase 6 | | | | | | |
Cancer | | Disease | Target | ATF-2 Protein | | | | | | |
Arthritis | | Disease | Drug | Acitretin (Soriatane)- FDA | | | | | | |
Depression | | Disease | Drug | Acitretin (Soriatane)- FDA | | | | | | |
Seizure | | Disease | Target | ATF-2 Protein | | | | | | |
Carcinoma | | Disease | Target | AMY1A | | | | | | |
Thrombocytopenia | | Disease | Drug | Angiomax (Bivalirudin)- FDA | | | | | | |
Alitretinoin (Panretin)- FDA | | Drug | Drug | Acitretin (Soriatane)- FDA | | | | | | |
Renin | | Target | Target | AMY1A | | | | | | |
Thromboembolism | | Disease | Drug | Angiomax (Bivalirudin)- FDA | | | | | | |
Glutathione Peroxidase 3 | | Target | Target | Glutathione Peroxidase 6 | | | | | | |
Adalimumab (Humira)- FDA | | Drug | Drug | Acitretin (Soriatane)- FDA | | | | | | |
Bronchitis | | Disease | Drug | Alpha (Prolastin)- FDA | | | | | | |
Depression | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Adenosine A1 Receptor | | Target | Target | Sulfonylurea Receptor 2b | | | | | | |
Attention Deficit Hyperactivity Disorder | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Androgen Receptor | | Target | Target | Sulfonylurea Receptor 2b | | | | | | |
Infection | | Disease | Target | Glutathione Peroxidase 6 | | | | | | |
Migraine | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Aggression | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Stroke | | Disease | Drug | Angiomax (Bivalirudin)- FDA | | | | | | |
Bipolar Affective Disorder | | Disease | Target | Tachykinin Receptor 1 | | | | | | |
Brain Injury | | Disease | Target | ATF-2 Protein | | | | | | |
Thrombocytopenia | | Disease | Drug | Adcetris (Brentuximab Vedotin)- FDA | | | | | | |
Hyperglycemia | | Disease | Drug | Adcetris (Brentuximab Vedotin)- FDA | | | | | | |
Cholesterol | | Disease | Disease | Leprosy Lepromatous | | | | | | |
Chronic Lymphocytic Leukemia | | Disease | Drug | Arranon (Nelarabine)- FDA | | | | | | |
Leukemia | | Disease | Drug | Arranon (Nelarabine)- FDA | | | | | | |
Tuberculosis | | Disease | Disease | Leprosy Lepromatous | | | | | | |
Leukemias | | Disease | Drug | Arranon (Nelarabine)- FDA | | | | | | |
Brain Tumors | | Disease | Drug | Arranon (Nelarabine)- FDA | | | | | | |
Anemia | | Disease | Drug | Adcetris (Brentuximab Vedotin)- FDA | | | | | | |
Pain | | Disease | Drug | Arranon (Nelarabine)- FDA | | | | | | |
Seizures | | Disease | Drug | Arranon (Nelarabine)- FDA | | | | | | |
Obesity | | Disease | Target | 5-Hydroxytryptamine 6 Receptor | | | | | | |
Nausea | | Disease | Drug | Adcetris (Brentuximab Vedotin)- FDA | | | | | | |